Disorders of mitochondrial fatty acyl‐CoA β‐oxidation
The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Abstract
In recent years tremendous progress has been made with respect to the enzymology of the mitochondrial fatty acid β‐oxidation machinery and defects therein. Firstly, a number of new mitochondrial β‐oxidation enzymes have been identified, including very‐long‐chain acyl‐CoA dehydrogenase (VLCAD) and mitochondrial trifunctional protein (MTP). Secondly, the introduction of tandem MS for the analysis of plasma acylcarnitines has greatly facilitated the identification of patients with a defect in fatty acid oxidation (FAO). These two developments explain why the number of defined FAO disorders has increased dramatically, making FAO disorders the most rapidly growing group of inborn errors of metabolism. In this review we describe the current state of knowledge of the enzymes involved in the mitochondrial oxidation of straight‐chain, branched‐chain and (poly)unsaturated fatty acyl‐CoAs as well as disorders of fatty acid oxidation. The laboratory diagnosis of these disorders is described, with particular emphasis on the methods used to identify the underlying enzyme defect and the molecular mutations. In addition, a simple flowchart is presented as a guide to the identification of mitochondrial FAO‐disorders. Finally, treatment strategies are discussed briefly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients afflicted with these disorders present with nonketotic hypoglycemia, muscle weakness, pronounced elevations in long chain acylcarnitines and systemic carnitine depletion [91].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [91]
Citations
Cites
Ciabarra, A., Sullivan, J., Gahn, L., Pecht, G., Heinemann, S., & Sevarino, K. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06498.1995 · Cited by 1,233
(2008) · Encyclopedia of Molecular Pharmacology · doi:10.1007/978-3-540-38918-7_6838 · Cited by 648
Millington, D. S., Kodo, N., Norwood, D. L., & Roe, C. R. (1990) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799385 · Cited by 571 · cited 1×
“…clear, however, that tandem mass spectrometry is the method of choice for the analysis of acylcarnitines, especially since acylcarnitine proÐles can readily be determined not only in plasma or serum samples but also in blood spots (Millington et al 1990 ; Rashed et al 1995a,b ; Vreken et al 1999).”
Muscle Carnitine Palmityltransferase Deficiency and Myoglobinuria
DiMauro, S., & DiMauro, P. M. M. (1973) · Science · doi:10.1126/science.182.4115.929 · Cited by 477 · cited 2×
“Schaefer and coworkers (1996) described three adult patients from the same family with symptoms of recurrent exercise-induced rhabdomyolysis mimicking adult-type CPT2 deÐciency (DiMauro and DiMauro 1973) except that these patients had an associated peripheral neuropathy.”
BackgroundRashed, M. S., Ozand, P. T., Bucknall, M. P., & Little, D. (1995) · Pediatric Research · doi:10.1203/00006450-199509000-00009 · Cited by 342 · cited 2×
“The proÐle of acylcarnitines in plasma obtained by tandem MS is unique and speciÐc for MCAD deÐciency characterized by elevated concentrations of together with elevated concentrations ofC8-carnitine and (Chace et al 1997 ; Rashed et al 1995b ; Vreken etC6-, C10- C10>1-acylcarnitine al 1999).”
BackgroundUchida, Y., Izai, K., Orii, T., & Hashimoto, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48391-3 · Cited by 339 · cited 9×
“It is now clear that the long-chain enzyme identiÐed by Schulz (1974) is in fact a constituent of the mitochondrial trifunctional protein (MTP) identiÐed by Hashimoto and coworkers (Uchida et al 1992).”
BackgroundInfluentialAndresen, B. S., Olpin, S., Poorthuis, B. J. H. M., Scholte, H. R., Vianey-Saban, C., Wanders, R., Ijlst, L., Morris, A., Pourfarzam, M., Bartlett, K., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302261 · Cited by 305 · cited 2×
“Since these reports in 1993, many additional VLCADdeÐcient patients have been described (Andresen et al 1996, 1999 ; Aoyama et al 1995a,b ; Brown-Harrison et al 1996 ; Largilliere et al 1995 ; Merinero et al 1996 ; Ogilvie et al 1994 ; Sluysmans et al 1997 ; Smelt et al 1998) including a series of…”
BackgroundSelf-citationChace, D. H., Hillman, S. L., Van Hove, J. L. K., & Naylor, E. W. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.11.2106 · Cited by 280 · cited 1×
“The proÐle of acylcarnitines in plasma obtained by tandem MS is unique and speciÐc for MCAD deÐciency characterized by elevated concentrations of together with elevated concentrations ofC8-carnitine and (Chace et al 1997 ; Rashed et al 1995b ; Vreken etC6-, C10- C10>1-acylcarnitine al 1999).”
BackgroundRashed, M. S., Bucknall, M. P., Little, D., Awad, A., Jacob, M., Alamoudi, M., Alwattar, M., & Ozand, P. T. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.7.1129 · Cited by 275
Medium–chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children
Iafolla, A. K., Thompson, R. J., & Roe, C. R. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70363-9 · Cited by 274
Research works printed but not linked: 1
- VredendaalPJ van denBergIET StroobantsAK Van DerADL MalingreHE BergerR(1999)Structural organisation of the human short‐chainL‐3‐hydroxyacyl‐CoA dehydrogenase gene.Mamm Genome(in press)..
Cited by
A general introduction to the biochemistry of mitochondrial fatty acid β‐oxidation
Houten, S. M., & Wanders, R. J. A. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9061-2 · Cited by 1,020
“For almost each enzyme involved in FAO, inherited defects have been described (Wanders et al. 1999; Rinaldo et al. 2002).”
BackgroundSelf-citationFatty Acid Oxidation Disorders
Rinaldo, P., Matern, D., & Bennett, M. J. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.154705 · Cited by 479
The Properties of Lauric Acid and Their Significance in Coconut Oil
Dayrit, F. M. (2015) · Journal of the American Oil Chemists' Society · doi:10.1007/s11746-014-2562-7 · Cited by 479
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Liu, Y. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500879 · Cited by 433
Control of mitochondrial β-oxidation flux
Eaton, S. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00024-8 · Cited by 411
Manzo, T., Prentice, B. M., Anderson, K. G., Raman, A., Schalck, A., Codreanu, G. S., Nava Lauson, C. B., Tiberti, S., Raimondi, A., Jones, M. A., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191920 · Cited by 342
“…energy demand may induce lethargy, hypoketotic hypoglycemia, coma, and death, especially during fasting, viral illnesses, and prolonged physical exercise, because of a severe energy deficiency and the accumulations of toxic acylcarnitines (Wanders et al., 1999; Spiekerkoetter et al., 2003).”
BackgroundMitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies
Wajner, M., & Amaral, A. U. (2016) · Bioscience Reports · doi:10.1042/bsr20150240 · Cited by 230
Fatty acid omega‐oxidation as a rescue pathway for fatty acid oxidation disorders in humans
Wanders, R. J. A., Komen, J., & Kemp, S. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07947.x · Cited by 218
Self-citationWanders, R. J. A., Ruiter, J. P. N., IJlst, L., Waterham, H. R., & Houten, S. M. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9104-8 · Cited by 214
“Since ferricenium hexafluorophosphate was (and is) commercially available, we (Wanders et al. 1999; Oey et al. 2006) devised a new type of assay for measurement of ACAD activities, which involves the use of ferricenium hexafluorophosphate as electron acceptor followed by the analysis of the…”
Self-citationFerdinandusse, S., Denis, S., Mooijer, P. A. W., Zhang, Z., Reddy, J. K., Spector, A. A., & Wanders, R. J. A. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31527-3 · Cited by 208
Self-citationThe Diverse Roles of Flavin CoenzymesNature's Most Versatile Thespians
Mansoorabadi, S. O., Thibodeaux, C. J., & Liu, H.-W. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo0703092 · Cited by 198
den Boer, M. E. J., Wanders, R. J. A., Morris, A. A. M., IJlst, L., Heymans, H. S. A., & Wijburg, F. A. (2002) · Pediatrics · doi:10.1542/peds.109.1.99 · Cited by 198
Self-citationGregersen, N., Andresen, B. S., Corydon, M. J., Corydon, T. J., Olsen, R. K. J., Bolund, L., & Bross, P. (2001) · Human Mutation · doi:10.1002/humu.1174 · Cited by 199
Acute Fatty Liver of Pregnancy
Ko, H. H., & Yoshida, E. (2006) · Canadian Journal of Gastroenterology · doi:10.1155/2006/638131 · Cited by 168
Subcellular localization and physiological role of α-methylacyl-CoA racemase
Ferdinandusse, S., Denis, S., IJlst, L., Dacremont, G., Waterham, H. R., & Wanders, R. J. A. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31983-0 · Cited by 184
Self-citationLack of mitochondrial trifunctional protein in mice causes neonatal hypoglycemia and sudden death
Ibdah, J. A., Paul, H., Zhao, Y., Binford, S., Salleng, K., Cline, M., Matern, D., Bennett, M. J., Rinaldo, P., & Strauss, A. W. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12590 · Cited by 181
Spiekerkoetter, U. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9090-x · Cited by 170
“Long-chain fatty acid oxidation defects were characterized by high morbidity and mortality before the newborn screening era (Wanders et al. 1999).”
BackgroundAmmonia Metabolism and Hyperammonemic Disorders
(2014) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2014.09.002 · Cited by 166
Functional and structural properties of mammalian acyl-coenzyme A thioesterases
Kirkby, B., Roman, N., Kobe, B., Kellie, S., & Forwood, J. K. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.04.001 · Cited by 163
“The requirement for free CoASH within mitochondria is very high, as it is a critical intermediate of the citric acid cycle, b-oxidation and other metabolic pathways; therefore, a readily available supply is essential for optimal mitochondrial function [8,40].”
BackgroundPeroxisomal branched chain fatty acid ?-oxidation pathway is upregulated in prostate cancer
Zha, S., Ferdinandusse, S., Hicks, J. L., Denis, S., Dunn, T. A., Wanders, R. J., Luo, J., De Marzo, A. M., & Isaacs, W. B. (2005) · The Prostate · doi:10.1002/pros.20177 · Cited by 164
Self-citationFerdinandusse, S., Denis, S., van Roermund, C. W. T., Wanders, R. J. A., & Dacremont, G. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300512-jlr200 · Cited by 143
Self-citationSevere hepatic dysfunction in pregnancy
Rahman, T. M., & Wendon, J. (2002) · QJM · doi:10.1093/qjmed/95.6.343 · Cited by 154
Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?
Muoio, D. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.11.007 · Cited by 137
Current issues regarding treatment of mitochondrial fatty acid oxidation disorders
Spiekerkoetter, U., Bastin, J., Gillingham, M. B., Morris, A. A. M., Wijburg, F. A., & Wilcken, B. M. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9188-1 · Cited by 133
“Before newborn screening for these disorders, FAO disorders were characterized by high morbidity and mortality (Wanders et al. 1999) and required strict treatment measures.”
BackgroundSelf-citationHepatic Fatty Acid Oxidation Restrains Systemic Catabolism during Starvation
Lee, J., Choi, J., Scafidi, S., & Wolfgang, M. J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.062 · Cited by 137
“The importance of fatty acid b-oxidation is made evident by multiple inborn errors in this pathway that cause serious human disease (Brivet et al., 1999; Longo et al., 2006;Wanders et al., 1999).”
Mitochondrial long chain fatty acid β-oxidation in man and mouse
Chegary, M., Brinke, H. T., Ruiter, J. P. N., Wijburg, F. A., Stoll, M. S. K., Minkler, P. E., van Weeghel, M., Schulz, H., Hoppel, C. L., Wanders, R. J. A., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.05.006 · Cited by 122
Self-citation2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency Is Caused by Mutations in the HADH2 Gene
Ofman, R., Ruiter, P. N. J., Feenstra, M., Durán, M., Poll‐The, B. T., Zschocke, J., Ensenauer, R. E., Lehnert, W., Sass, J. O., Sperl, W., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375116 · Cited by 122
Spiekerkoetter, U., Sun, B., Khuchua, Z. A., Bennett, M. J., & Strauss, A. W. (2003) · Human Mutation · doi:10.1002/humu.10211 · Cited by 121
“[1989] described a child with sudden infant death syndrome (SIDS) and accumulation of long-chain 3-hydroxy-fatty acids, TFP defects have been molecularly characterized [Wanders et al., 1992; Brackett et al., 1995; Ushikubo et al., 1996; Wanders et al., 1999; den Boer et al., 2002].”
BackgroundMethodInfluentialFingerhut, R., Röschinger, W., Muntau, A. C., Dame, T., Kreischer, J., Arnecke, R., Superti-Furga, A., Troxler, H., Liebl, B., Olgemöller, B., et al. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.10.1763 · Cited by 116
Spiekerkoetter, U., Sun, B., Zytkovicz, T. H., Wanders, R. J. A., Strauss, A. W., & Wendel, U. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00292-0 · Cited by 111
“The reaction product was quantified by high-pressure liquid chromatography.(16)”
MethodSelf-citationShekhawat, P., Matern, D., & Strauss, A. W. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000159631.63843.3e · Cited by 116
Compartmentalized Acyl-CoA Metabolism in Skeletal Muscle Regulates Systemic Glucose Homeostasis
Li, L. O., Grevengoed, T. J., Paul, D. S., Ilkayeva, O., Koves, T. R., Pascual, F., Newgard, C. B., Muoio, D. M., & Coleman, R. A. (2015) · Diabetes · doi:10.2337/db13-1070 · Cited by 106
Clark-Taylor, T., & Clark-Taylor, B. E. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.01.011 · Cited by 111
Spiekerkoetter, U., Khuchua, Z. A., Yue, Z., Bennett, M. J., & Strauss, A. W. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000103931.80055.06 · Cited by 102
“Enzyme activities were measured according to previously reported techniques (7).”
MethodMitochondrial Fatty Acid β-Oxidation Disorders: From Disease to Lipidomic Studies—A Critical Review
Guerra, I. M. S., Ferreira, H. B., Melo, T., Rocha, H., Moreira, S., Diogo, L. M., Domingues, M. R., & Moreira, A. S. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213933 · Cited by 110
“The short-chain acyl-CoA dehydrogenase (SCAD) acts on substrates with a chain length between C4 and C6, the medium-chain acyl-CoA dehydrogenase (MCAD) acts on C6 to C12 substrates, and the very long chain acyl-CoA dehydrogenase (VLCAD) is active with substrates ranging from C14 to C24 [16,23,25].”
BackgroundInfluentialDisorders of muscle lipid metabolism: Diagnostic and therapeutic challenges
Laforêt, P., & Vianey‐Saban, C. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.06.018 · Cited by 108
Strategies for the diagnosis of mitochondrial fatty acid β-oxidation disorders
Sim, K. G., Hammond, J. W., & Wilcken, B. M. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00182-1 · Cited by 119
Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia
El-Ansary, A. K., Ben Bacha, A. G., & Al- Ayahdi, L. Y. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-62 · Cited by 94
Djouadi, F., Aubey, F., Schlemmer, D., Ruiter, J. P. N., Wanders, R. J. A., Strauss, A. W., & Bastin, J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi303 · Cited by 96
“VLCAD activity was measured as described elsewhere ( 24 ) using palmitoyl-CoA as substrate.”
MethodSelf-citationLong-Chain Fatty Acid Oxidation during Early Human Development
Oey, N. A., den Boer, M. E. J., Wijburg, F. A., Vekemans, M. J. J., Augé, J., Steiner, C., Wanders, R. J. A., Waterham, H. R., Ruiter, J. P. N., & Attié‐Bitach, T. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000161413.42874.74 · Cited by 97
“The activity of VLCAD was measured as described elsewhere (17), using palmitoyl-CoA as substrates.”
MethodSelf-citationMahmoudianDehkordi, S., Ahmed, A. T., Bhattacharyya, S., Han, X., Baillie, R. A., Arnold, M., Skime, M. K., John-Williams, L. S., Moseley, M. A., Thompson, J. W., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01097-6 · Cited by 95
Inborn Errors of Metabolism with Myopathy
El‐Gharbawy, A., & Vockley, J. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.11.006 · Cited by 94
Badenhorst, C. P. S., van der Sluis, R., Erasmus, E., & van Dijk, A. A. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.796929 · Cited by 109
“becomes limiting, energy metabolism is impacted on several levels [13,14,33].”
BackgroundInfluentialden Boer, M. E. J., Dionisi‐Vici, C., Chakrapani, A., van Thuijl, A. O. J., Wanders, R. J. A., & Wijburg, F. A. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.231 · Cited by 92
Self-citationSevere hyperammonaemia in adults not explained by liver disease
Walker, V. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2011.011206 · Cited by 93
Defects of mitochondrial β-oxidation: a growing group of disorders
Vockley, J. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(01)00308-x · Cited by 91
Reye's and Reye's‐like syndromes
Pugliese, A., Beltramo, T., & Torre, D. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1465 · Cited by 133
Rakheja, D., Bennett, M. J., Foster, B. M., Domiati‐Saad, R., & Rogers, B. B. (2002) · Placenta · doi:10.1053/plac.2002.0808 · Cited by 91
Koeberl, D. D., Young, S. P., Gregersen, N., Vockley, J., Smith, W. E., Benjamin, D. K., An, Y., Weavil, S. D., Chaing, S., Bali, D. S., et al. (2003) · Pediatric Research · doi:10.1203/01.pdr.0000074972.36356.89 · Cited by 88
Activation of human mitochondrial pantothenate kinase 2 by palmitoylcarnitine
Leonardi, R., Rock, C. O., Jackowski, S., & Zhang, Y.-M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607621104 · Cited by 85
Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability
Olpin, S. E. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9611-5 · Cited by 89
“…defects in 17 proteins directly affecting either carnitine dependent transport of long chain fatty acids or the process of β-oxidation itself have so far been described (Bennett et al 2000; Wanders et al 1999; Rinaldo et al 2002; Wanders et al 2010; Spiekerkoetter 2010; Houten and Wanders 2010).”
BackgroundRibas, G. S., & Vargas, C. R. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00955-7 · Cited by 84
Gloerich, J., van Vlies, N., Jansen, G. A., Denis, S., Ruiter, J. P. N., van Werkhoven, M. A., Duran, M., Vaz, F. M., Wanders, R. J. A., & Ferdinandusse, S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400337-jlr200 · Cited by 80
“SCAD, MCAD, and very long-chain acyl-CoA dehydrogenase (VLCAD) activity measurements were performed using HPLC analysis ( 39 ).”
MethodSelf-citationFatty acid metabolism by the osteoblast
Kushwaha, P., Wolfgang, M. J., & Riddle, R. C. (2017) · Bone · doi:10.1016/j.bone.2017.08.024 · Cited by 85
De Feyter, H. M., Lenaers, E., Houten, S. M., Schrauwen, P., Hesselink, M. K., Wanders, R. J. A., Nicolay, K., & Prompers, J. J. (2008) · The FASEB Journal · doi:10.1096/fj.08-112318 · Cited by 77
“Very long chain acyl-CoA dehydrogenase (VLCAD) activity was measured as described elsewhere, using palmitoyl-CoA as substrate ( 36 ).”
MethodSelf-citationGobin, S., Djouadi, F., Aubey, F., Olpin, S. E., Andresen, B. S., Yamaguchi, S., Mandel, H., Fukao, T., Ruiter, J. P. N., Wanders, R. J. A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/522375 · Cited by 78
Self-citationScreening for Carnitine Palmitoyltransferase II Deficiency by Tandem Mass Spectrometry
Gempel, K., Kiechl, S., Hofmann, S., Lochmüller, H., Kiechl‐Kohlendorfer, U., Willeit, J., Sperl, W., Rettinger, A., Bieger, I., Pongratz, D., et al. (2002) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1015109127986 · Cited by 74
“The differential diagnosis of CPT II de¢ciency is mainly that of paroxysmal metabolic myoglobinuria, exogenously induced myoglobinuria and exercise-related myalgia (Wanders et al 1999).”
BackgroundOkun, J. G., Kölker, S., Schulze, A., Kohlmüller, D., Olgemöller, K., Lindner, M. S., Hoffmann, G. F., Wanders, R. J. A., & Mayatepek, E. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00296-2 · Cited by 75
Self-citationWomen Have Higher Protein Content of β-Oxidation Enzymes in Skeletal Muscle than Men
Maher, A. C., Akhtar, M., Vockley, J., & Tarnopolsky, M. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012025 · Cited by 72
Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models
Spiekerkoetter, U., & Wood, P. A. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9121-7 · Cited by 72
“In humans, long-chain FAO defects present with heterogeneous clinical phenotypes mainly affecting three different organ systems: heart, liver, and skeletal muscles (Wanders et al. 1999).”
Identification of isobutyryl-CoA dehydrogenase and its deficiency in humans
Nguyen, T. V., Andresen, B. S., Corydon, T. J., Ghisla, S., Abdel-Razik, N. E., Mohsen, A.-W. A., Cederbaum, S. D., Roe, D. S., Roe, C. R., Lench, N., et al. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00152-x · Cited by 70
Neonatal screening for defects of the mitochondrial trifunctional protein
Sander, J., Sander, S., Steuerwald, U., Janzen, N., Peter, M., Wanders, R. J. A., Marquardt, I., Korenke, G. C., & Das, A. M. (2005) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.02.002 · Cited by 68
Self-citationInborn Errors of Energy Metabolism Associated with Myopathies
Das, A. M., Steuerwald, U., & Illsinger, S. (2010) · BioMed Research International · doi:10.1155/2010/340849 · Cited by 68
“In the mitochondrial matrix space, acylcarnitines are reconverted to acyl-CoA via carnitine-palmitoyltransferase 2 (CPT2) (Figure 1) and subsequently enter beta-oxidation [5].”
BackgroundLauric acid is a medium-chain fatty acid, coconut oil is a medium-chain triglyceride
Dayrit, F. M. (2014) · Cited by 102
Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency
Diekman, E. F., Ferdinandusse, S., van der Pol, W. L., Waterham, H. R., Ruiter, J. P. N., IJlst, L., Wanders, R. J. A., Houten, S. M., Wijburg, F. A., Blank, A. C., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.22 · Cited by 65
Self-citationSchymik, I., Liebig, M., Mueller, M., Wendel, U., Mayatepek, E., Strauss, A. W., Wanders, R. J. A., & Spiekerkoetter, U. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.02.037 · Cited by 64
Self-citationOey, N. A., den Boer, M. E. J., Ruiter, J. P. N., Wanders, R. J. A., Durán, M., Waterham, H. R., Boer, K., van der Post, J., & Wijburg, F. A. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1025163204165 · Cited by 66
“The importance of the mitochondrial fatty acid oxidation is stressed by the existence of a variety of different genetic diseases in man in which mitochondrial b-oxidation is impaired (Wanders et al 1999).”
BackgroundMethodInfluentialSelf-citationMolecular and functional characterisation of mild MCAD deficiency
Zschocke, J., Schulze, A., Lindner, M. S., Fiesel, S., Olgemöller, K., Hoffmann, G. F., Penzien, J. M., Ruiter, J. P. N., Wanders, R. J. A., & Mayatepek, E. (2001) · Human Genetics · doi:10.1007/s004390100501 · Cited by 64
Self-citationDerks, T. G. J., Boer, T. S., van Assen, A., Bos, T., Ruiter, J. P. N., Waterham, H. R., Niezen‐Koning, K. E., Wanders, R. J. A., Rondeel, J. M. M., Loeber, J. G., et al. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0492-3 · Cited by 63
“Two different methods were used: the GC-MS-based assay with hexanoyl-CoA described above, and an HPLC-based assay in which phenylpropionyl-CoA was used as substrate, as published previously (Wanders et al 1999; Yao and Schulz 1993).”
BackgroundMethodSelf-citationHoffmann, L., Haussmann, U., Mueller, M., & Spiekerkoetter, U. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9391-8 · Cited by 63
“Determination of palmitoyl-CoA oxidation in lymphocytes Determination of residual VLCAD activity was performed as published earlier (Liebig et al. 2006; Spiekerkoetter et al. 2010; Wanders et al. 1999).”
MethodMcDonald, A. E., Pichaud, N., & Darveau, C.-A. (2017) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2017.11.006 · Cited by 68
Liebig, M., Schymik, I., Mueller, M., Wendel, U., Mayatepek, E., Ruiter, J. P. N., Strauss, A. W., Wanders, R. J. A., & Spiekerkoetter, U. (2006) · PEDIATRICS · doi:10.1542/peds.2006-0666 · Cited by 58
Self-citationTransorgan fluxes in a porcine model reveal a central role for liver in acylcarnitine metabolism
Schooneman, M. G., Have, G. A. M. T., van Vlies, N., Houten, S. M., Deutz, N. E. P., & Soeters, M. R. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00503.2014 · Cited by 61
Adult presentations of medium‐chain acyl‐CoA dehydrogenase deficiency (MCADD)
Lang, T. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1202-0 · Cited by 57
“All the factors described are known to stress individuals metabolically and particularly the mitochondrial fatty acid oxidation pathway (Wanders et al. 1999).”
BackgroundInfluentialCarnitine palmitoyltransferase 1 facilitates fatty acid oxidation in a non-cell-autonomous manner
Choi, J., Smith, D. M., Scafidi, S., Riddle, R. C., & Wolfgang, M. J. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115006 · Cited by 59
The diagnostic challenge in very‐long chain acyl‐CoA dehydrogenase deficiency (VLCADD)
Hesse, J., Braun, C., Behringer, S., Matysiak, U., Spiekerkoetter, U., & Tucci, S. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0245-5 · Cited by 56
“Deficiency of one or more enzymes involved in the mitochondrial β-oxidation pathway may have severe consequences on human health with involvement of different organ systems (Wanders et al 1999).”
BackgroundViolante, S. N., IJlst, L., van LENTHE, H., de Almeida, I. T., Wanders, R. J. A., & Ventura, F. V. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.002 · Cited by 55
Self-citationPrip-Buus, C., Thuillier, L., Abadi, N., Prasad, C., Dilling, L., Klasing, J., Demaugre, F., Greenberg, C. R., Haworth, J. C., Droin, V., et al. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3176 · Cited by 54
Röschinger, W., Muntau, A. C., Durán, M., DORLAND, L., IJlst, L., Wanders, R. J. A., & Roscher, A. A. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00268-0 · Cited by 54
Self-citationAcute Fatty Liver of Pregnancy: A Retrospective Analysis of 56 Cases
Zhang, Y., Kong, W., Zhou, S., Gong, Y., & Zhou, R. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.181963 · Cited by 52
Van den Broek, N. M. A., Ciapaite, J., De Feyter, H. M. M. L., Houten, S. M., Wanders, R. J. A., Jeneson, J. A. L., Nicolay, K., & Prompers, J. J. (2010) · The FASEB Journal · doi:10.1096/fj.09-143842 · Cited by 50
Self-citationDynamic mitochondrial responses to a high-fat diet in Drosophila melanogaster
Cormier, R. P. J., Champigny, C. M., Simard, C. J., St‐Cœur, P., & Pichaud, N. (2019) · Scientific Reports · doi:10.1038/s41598-018-36060-5 · Cited by 56
Overview of the Physiological Control of Eating
Langhans, W., & Geary, N. (2010) · Forum of Nutrition · doi:10.1159/000264392 · Cited by 48
Kao, H.-J., Cheng, C.-F., Chen, Y.-H., Hung, S.-I., Huang, C.-C., Millington, D., Kikuchi, T., Wu, J.-Y., & Chen, Y.-T. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl433 · Cited by 47
Diagnosis and management of defects of mitochondrial β-oxidation
Vockley, J., Singh, R. H., & Whiteman, D. A. H. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200211000-00002 · Cited by 47
Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization
Peng, M., Liu, L., Jiang, M., Liang, C., Zhao, X., Cai, Y., Sheng, H., Ou, Z., & Hong, L. (2013) · Journal of Chromatography B · doi:10.1016/j.jchromb.2013.05.028 · Cited by 46
Spiekerkoetter, U., Haussmann, U., Mueller, M., ter Veld, F., Stehn, M., Santer, R., & Lukács, Z. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.04.063 · Cited by 46
“Palmitoyl-CoA oxidation was performed as previously reported with high-pressure liquid chromatography.(6,12) Currently, the same assay also is available with MS/ MS and has been reported in detail.”
MethodAcute fatty liver of pregnancy: a retrospective study of 32 cases in South China
Cheng, N., Xiang, T., Wu, X., Ming, L., Xie, Y., & Zhang, L. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.871704 · Cited by 47
Urine Organic Acids as Potential Biomarkers for Autism-Spectrum Disorder in Chinese Children
Chen, Q., Qiao, Y., Xu, X., You, X., & Tao, Y. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00150 · Cited by 51
ter Veld, F., Primaßin, S., Hoffmann, L., Mayatepek, E., & Spiekerkoetter, U. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800221-jlr200 · Cited by 45
Pennisi, E. M., Garibaldi, M., & Antonini, G. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120472 · Cited by 44
Long-Chain L-3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency: A Molecular and Biochemical Review
Rakheja, D., Bennett, M. J., & Rogers, B. B. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000021175.50201.46 · Cited by 49
Goetzman, E. S., Wang, Y., He, M., Mohsen, A.-W. A., Ninness, B. K., & Vockley, J. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.01.013 · Cited by 43
“Clinical disease results from genetic deficiencies of the ACD family [1–4].”
BackgroundDynamic simulations on the mitochondrial fatty acid Beta-oxidation network
Modre‐Osprian, R., Osprian, I., TILG, B., Schreier, G., Weinberger, K. M., & Graber, A. (2009) · BMC Systems Biology · doi:10.1186/1752-0509-3-2 · Cited by 42
Browning, M. F., Larson, C. A., Strauss, A. W., & Marsden, D. (2004) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-005-0545-4 · Cited by 42
Fatty acid oxidation in the human fetus: Implications for fetal and adult disease
Oey, N. A., Ruiter, J. P. N., Attié‐Bitach, T., IJlst, L., Wanders, R. J. A., & Wijburg, F. A. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0199-x · Cited by 42
“The activity of MCAD was measured using phenylpropionyl-CoA as substrate (Wanders et al 1999).”
MethodSelf-citationNaiki, M., Ochi, N., Kato, Y. S., Purevsuren, J., Yamada, K., Kimura, R., Fukushi, D., Hara, S., Yamada, Y., Kumagai, T., et al. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36434 · Cited by 41
“…is characterized by a wide range of clinical features, including cardiomyopathy, hypoketonic hypoglycemia, metabolic acidosis, sudden infant death, metabolic encephalopathy, liver dysfunction, peripheral neuropathy, exercise-induced myoglobinuria, and rhabdomyolysis [Wanders et al., 1999].”
BackgroundDas, A. M., Lücke, T., Meyer, U., Hartmann, H., & Illsinger, S. (2010) · Annals of Nutrition and Metabolism · doi:10.1159/000283242 · Cited by 40
Luo, X., Liu, W., Zhao, M., Huang, Y. S., & Feng, F. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.05.017 · Cited by 40
Preeclampsia and HELLP Syndrome: Impaired Mitochondrial Function in Umbilical Endothelial Cells
Illsinger, S., Janzen, N., Sander, S., Schmidt, K., Bednarczyk, J., Mallunat, L., Bode, J., Hagebölling, F., Hoy, L., Lücke, T., et al. (2010) · Reproductive Sciences · doi:10.1177/1933719109351597 · Cited by 43
Metadata
- Authors
- Wanders, R. J. A., Vreken, P., den Boer, M. E. J., Wijburg, F. A., Van Gennip, A. H., & IJlst, L.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Departments of Clinical Chemistry Academic Medical Center, University of Amsterdam The Netherlands
- Corresponding author
- Wanders, R. J. A.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 1999-06
- Volume
- 22
- Issue
- 4
- Pages
- 442-487
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2147457396
- Cited by
- 257
- References
- 180
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 12 · 2023: 4 · 2022: 9 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 8 · 2015: 7 · 2014: 12 · 2013: 13 · 2012: 5
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Inherited Metabolic Disease (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- fatty acid beta-oxidation disorders, inborn errors of metabolism, VLCAD, mitochondrial trifunctional protein, acylcarnitines, tandem mass spectrometry, branched-chain fatty acids, polyunsaturated fatty acids, enzyme defects, molecular diagnosis, treatment options
- MeSH terms
- Acyl Coenzyme A, Fatty Acids, Fatty Acids, Unsaturated, Humans, Lipid Metabolism, Inborn Errors, Mitochondria, Oxidation-Reduction, Prenatal Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.